pneumonia%20-%20hospital-acquired
PNEUMONIA - HOSPITAL-ACQUIRED
Hospital-acquired pneumonia (HAP) is defined as pneumonia occurring ≥48 hours after admission and excluding any infection that is incubating at the time of admission.
Ventilator-associated pneumonia (VAP) is described as pneumonia occurring >48-72 hours after endotracheal intubation and within 48 hours after removal of endotracheal tube.
Early-onset HAP or VAP is the pneumonia occurring within the first 4 days of hospitalization that may be cause by antibiotic-sensitive bacteria that usually carries a better diagnosis.
Late-onset HAP or VAP is the pneumonia occurring after ≥5 days. It is likely caused by multidrug-resistant pathogens associated with increased mortality and morbidity.

Introduction

Healthcare-associated Pneumonia (HCAP)
  • Pneumonia occurring in any patient who was hospitalized w/in an acute care hospital for ≥2 days, w/in 90 days of the infection; resided in a nursing home/long-term care facility; received recent IV antibiotic therapy, chemotherapy or wound care w/in the past 30 days of the current infection; or attended a hospital or hemodialysis clinic

Definition

Hospital-acquired Pneumonia (HAP)
  • Defined as pneumonia occurring ≥48 hours after admission & excluding any infection that is incubating at the time of admission
Ventilator-associated Pneumonia (VAP)
  • Described as pneumonia occurring >48-72 hours after endotracheal intubation & w/in 48 hours after removal of endotracheal tube
Early-onset HAP or VAP
  • Pneumonia occurring w/in the first 4 days of hospitalization
  • May be caused by antibiotic-sensitive bacteria, usually carries a better prognosis
Late-onset HAP or VAP
  • Pneumonia occurring after ≥5 days
  • Likely to be caused by multidrug-resistant (MDR) pathogens, associated w/ increased mortality & morbidity

Signs and Symptoms

Typical Signs & Symptoms
  • Fever
  • Cough w/ or w/o sputum production
  • Purulent sputum
  • Dyspnea; shortness of breath (SOB)
  • Respiratory failure
Other Findings
  • Worsening oxygenation
  • Increased heart rate
  • Increased minute ventilation

Risk Factors

  • ≥5 days duration stay for the current hospitalization
  • High antibiotic resistance in the community or w/in the specific treatment unit
  • Antibiotics w/in the preceding 90 days
  • Immunosuppressive disease &/or therapy
  • Presence of healthcare-associated pneumonia (HCAP) risk factors:
    • Chronic dialysis w/in 30 days
    • Family member w/ multidrug-resistant (MDR)  organism
    • Home infusion therapy (including antibiotics)
    • Home wound care
    • Hospitalization for ≥2 days w/in the previous 90 days
    • Resident of nursing home/long-term care facility
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Pearl Toh, 19 Jun 2016
Infants with persistent rhinitis have a higher abundance of Actinobacteria, especially Corynebacterium spp., in their nasal microbiome compared with healthy controls, according to a Singapore-based study presented at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Congress 2016 held in Vienna, Austria.
Gabriel Angelo Sembrano, 16 Sep 2014

“At present, there is a limited development of new antibiotics. There is also a fast development of resistance to antibiotics. There are pathogens no longer susceptible to all antibiotics, and many pathogens are no longer susceptible to most antibiotics,” said Dr. Andre Villanueva, chief of party of the USAID’s Innovations and Multisectoral Partnerships to Achieve Control of TB (IMPACT) Project at the recent Annual Convention of the Philippine Pharmacists’ Association in Davao City.

Audrey Abella, 06 Jan 2017
Persistent wheeze or childhood asthma may be reduced by fish oil supplementation, particularly n-3 long-chain polyunsaturated fatty acids (LCPUFAs), during pregnancy, a recent Danish study found.
Pearl Toh, 31 May 2016
Synbiotic mixture of oligosaccharides and Bifidobacterium breve (B. breve) M-16V probiotic strain in infant formula restores gut colonisation by B. breve and supports healthy gut development in infants delivered by Caesarean-section (C-section), according to a study presented at the recent European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) annual meeting held in Athens, Greece.